3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for biotech and pharma companies. Their offerings include protein expression and production platforms based on microbial strains and mammalian cells, plasmid DNA, and viral vectors for adenovirus and adeno-associated virus (AAV) used in gene therapy, as well as cell therapy products. Additionally, the company offers fill and finish services for recombinant proteins and viral vectors.
3PBIOVIAN operates manufacturing facilities in Pamplona-Noáin, Spain, and Turku, Finland, along with a commercial office in Boston, which efficiently supports the diverse needs of its clients. Their services cover everything from preclinical and clinical supply to large-scale commercial manufacturing of Drug Substance and Drug Product.
With over 30 years of combined experience in biologics drug manufacturing, 3PBIOVIAN was formed by the merger of 3P Biopharmaceuticals and BIOVIAN, uniting two leading European CDMOs.
Our service offerings include microbial and mammalian protein expression platforms, Viral Vector production for Adenoviruses and Adeno-associated viruses, Cell Therapy, and Plasmid DNA Production. Additionally, we provide Fill & Finish services for recombinant proteins and Viral Vectors.
We deliver specialized, end-to-end global CDMO services to biotech and pharma companies, providing high-quality solutions from process development through commercial cGMP manufacturing for both Drug Substance and Drug Product.